23 September 2015 Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data
Author Affiliations +
Abstract
Genomic and radiomic imaging profiles of invasive breast carcinomas from The Cancer Genome Atlas and The Cancer Imaging Archive were integrated and a comprehensive analysis was conducted to predict clinical outcomes using the radiogenomic features. Variable selection via LASSO and logistic regression were used to select the most-predictive radiogenomic features for the clinical phenotypes, including pathological stage, lymph node metastasis, and status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Cross-validation with receiver operating characteristic (ROC) analysis was performed and the area under the ROC curve (AUC) was employed as the prediction metric. Higher AUCs were obtained in the prediction of pathological stage, ER, and PR status than for lymph node metastasis and HER2 status. Overall, the prediction performances by genomics alone, radiomics alone, and combined radiogenomics features showed statistically significant correlations with clinical outcomes; however, improvement on the prediction performance by combining genomics and radiomics data was not found to be statistically significant, most likely due to the small sample size of 91 cancer cases with 38 radiomic features and 144 genomic features.
© 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)
Wentian Guo, Hui Li, Yitan Zhu, Li Lan, Shengjie Yang, Karen Drukker, Elizabeth A. Morris, Elizabeth S. Burnside, Gary J. Whitman, Maryellen L. Giger, Yuan Ji, TCGA Breast Phenotype Research Group, "Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data," Journal of Medical Imaging 2(4), 041007 (23 September 2015). https://doi.org/10.1117/1.JMI.2.4.041007 . Submission:
JOURNAL ARTICLE
12 PAGES


SHARE
Back to Top